Diagnose of GH-deficiency: comparing the reliability of a dietary-protein test with conventional Growth Hormone Stimuation Tests

Phase 3

Withdrawn

• Conditions: groeistoornissen; growth retardatrion; short-stature; 10021112

• Registration Number: NL-OMON31236
• Lead Sponsor: Wageningen Center for Food Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Eligibility for GHST's is based on one or more of the anthropometric criteria characterizing GH deficient patients:
* Height less than -2,5 SDS
* Deviation from target height more than 1.3 SDS
* Deviation of growth more than -0.25 SDS.

Exclusion Criteria

Children will be excluded if other reasons than those related to GH for growth retardation were present. Because it is known that girls with Turner syndrome show a growth response to GH therapy, they will be included in the tests.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>A difference in reliability in the diagnose of GH-deficiency with the GHST*s<br /><br>and the protein test, using TBW-test.<br /><br>TBW-test is the evaluation test in this study to compare the predicting power<br /><br>of the diagnostic tests. TBW-test is used to evaluate GH-therapy after 6 weeks. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>